loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Latest Rapid Results

Open Free Trading Account Online with ICICIDIRECT
+91

Q1FY27 Quarterly Result Announced for Sasken Technologies Ltd.

IT Consulting & Software company Sasken Technologies announced Q1FY27 results

Consolidated Financial Highlights:

  • Revenue from operations for Q1FY27 was reported at Rs 33,923.85 lakh, reflecting a growth of 1.6% compared to Rs 33,402.41 lakh in Q4FY26 and an increase of 24.0% from Rs 27,353.07 lakh in Q1FY26.
  • Total income for Q1FY27 reached Rs 34,891.03 lakh, a marginal decline of 0.13% from Rs 34,935.61 lakh in Q4FY26 and a growth of 24.1% from Rs 28,113.49 lakh in Q1FY26.
  • Profit before tax for Q1FY27 stood at Rs 2,957.09 lakh, representing a decrease of 21.0% compared to Rs 3,742.75 lakh in Q4FY26, while showing a significant growth of 146.2% from Rs 1,201.25 lakh in Q1FY26.
  • Profit after tax (Net Profit) for Q1FY27 was Rs 2,352.15 lakh, a decline of 18.9% from Rs 2,900.19 lakh in Q4FY26 and a growth of 135.1% compared to Rs 1,000.57 lakh in Q1FY26.
  • Other income for Q1FY27 was reported at Rs 967.18 lakh, compared to Rs 1,533.20 lakh in Q4FY26 and Rs 760.42 lakh in Q1FY26.
  • EBITDA for Q1FY27 was Rs 3,212.00 lakh (reported as Rs 321.20 million in the snapshot), showing a decline of 3.2% from Q4FY26 and an increase of 119.4% from Q1FY26.

Standalone Financial Highlights:

  • Revenue from operations for Q1FY27 stood at Rs 15,548.08 lakh, representing an increase of 7.47% from Rs 14,467.62 lakh in Q4FY26 and a growth of 31.38% from Rs 11,834.38 lakh in Q1FY26.
  • Total income reached Rs 16,940.18 lakh in Q1FY27, up 10.90% from Rs 15,275.37 lakh in Q4FY26 and up 30.95% from Rs 12,935.98 lakh in Q1FY26.
  • Profit after tax (Net Profit) for Q1FY27 was Rs 2,885.58 lakh, reflecting a growth of 46.20% compared to Rs 1,973.80 lakh in Q4FY26 and a significant increase of 214.62% from Rs 917.16 lakh in Q1FY26.
  • Profit before tax for Q1FY27 stood at Rs 3,644.23 lakh, compared to Rs 2,495.23 lakh in Q4FY26 and Rs 1,070.68 lakh in Q1FY26.

Business Highlights:

  • Segment Performance:
    • Software Services: Revenue for Q1FY27 was Rs 21,955.88 lakh, representing a growth of 4.8% QoQ and 24.3% YoY. The gross margin for this segment improved to 30.6% in Q1FY27 from 28.2% in Q4FY26.
    • Product Solutions: Revenue for Q1FY27 was Rs 11,967.97 lakh, showing a decline of 3.9% QoQ and a growth of 23.6% YoY. The gross margin for this segment was 5.9% in Q1FY27 compared to 12.8% in Q4FY26.
  • Order Book and Deals: The total contract value (TCV) booked during Q1FY27 stood at USD 47.1 million, with USD 33.7 million originating from new business. The company added five new logos during the quarter.
  • Customer Metrics: The active customer base expanded to 93 accounts. Revenue contribution from the top 5 customers was 50.8% and from the top 10 customers was 66.1%.
  • Operational Metrics: Global headcount stood at 2,658 at the close of Q1FY27, with 340 gross additions during the quarter. The utilization rate, including trainees, was 85.1%. Attrition (LTM) remained at 9.8%.
  • Geography Mix: Revenue contribution by geography for Q1FY27 was: North America (29.5%), EMEA (25.0%), India (25.9%), and APAC (19.6%).
  • Infrastructure: The company inaugurated a new Hyderabad office and the Sasken Silicon Incubation Centre in Hubballi during the quarter.
  • Subsidiary Acquisition: Celliimune Biotech Private Limited became a wholly owned subsidiary effective from April 02, 2026.

Rajiv C. Mody, CMD & CEO, Sasken Technologies, said: “The quarter reflects the continued progress we are making in building a more resilient and differentiated Sasken. Our growth is increasingly being shaped by deeper customer partnerships and our ability to bring a product mindset to every engagement, going beyond execution to shape customer roadmaps, accelerate innovation and contribute to their growth. Our Chip-toCognition capabilities set us apart, and we will build on this strength to deepen partnerships, expand our impact and create enduring value for all stakeholders.”

Result PDF

Q1FY27 Quarterly Result Announced for Axis Solutions Ltd.

IT Consulting & Software company Axis Solutions announced Q1FY27 results

Consolidated Financial Highlights:

  • Total Revenue from operations for Q1FY27 was reported at Rs 4,898.83 lakh, representing a YoY growth of 78.22% compared to Rs 2,748.73 lakh in Q1FY26 and a QoQ decline of 58.25% from Rs 11,734.42 lakh in Q4FY26.
  • Total Income for the quarter stood at Rs 4,906.05 lakh in Q1FY27, showing a YoY increase of 78.01% from Rs 2,756.10 lakh and a QoQ decline of 58.24% from Rs 11,749.32 lakh.
  • Net Profit attributable to the owners of the company for Q1FY27 was Rs 370.56 lakh, reflecting a YoY increase of 82.32% from Rs 203.25 lakh in Q1FY26, while decreasing by 77.41% QoQ from Rs 1,640.37 lakh in Q4FY26.
  • Total Comprehensive Income for the period reached Rs 309.70 lakh in Q1FY27, marking a YoY growth of 77.08% compared to Rs 174.89 lakh and a QoQ decline of 81.37% from Rs 1,662.48 lakh.
  • Other Income for Q1FY27 was recorded at Rs 7.22 lakh, compared to Rs 7.97 lakh in Q1FY26 and Rs 14.90 lakh in Q4FY26.
  • Earnings Per Share (Basic and Diluted) for Q1FY27 was reported at Rs 0.66, as against Rs 0.37 in Q1FY26 and Rs 3.52 in Q4FY26.

Standalone Financial Highlights:

  • Revenue from operations in Q1FY27 was Rs 4,867.05 lakh, reflecting a YoY growth of 77.45% from Rs 2,742.79 lakh in Q1FY26 and a QoQ decline of 58.21% compared to Rs 11,647.06 lakh in Q4FY26.
  • Total Income for Q1FY27 stood at Rs 4,874.27 lakh, representing a YoY increase of 77.20% from Rs 2,750.76 lakh and a QoQ decrease of 58.22% from Rs 11,667.51 lakh.
  • Net Profit for the period was reported at Rs 364.94 lakh in Q1FY27, showing a YoY growth of 65.21% from Rs 220.89 lakh and a QoQ decline of 76.79% from Rs 1,572.38 lakh in Q4FY26.
  • Total Comprehensive Income for Q1FY27 reached Rs 364.94 lakh, an increase of 65.21% YoY from Rs 220.89 lakh and a decrease of 76.93% QoQ from Rs 1,581.76 lakh.
  • Other Income for the quarter was Rs 7.22 lakh, compared to Rs 7.97 lakh in Q1FY26 and Rs 20.45 lakh in Q4FY26.
  • Earnings Per Share (Basic and Diluted) for Q1FY27 stood at Rs 0.77.

Business Highlights:

  • Amalgamation Update: Pursuant to an NCLT order dated 11th July 2024, Axis Solutions Private Limited was amalgamated with Asya Infosoft Limited with effect from 1st April 2023. The reorganization was conducted under the Insolvency and Banking Code, 2007.
  • Dividend and AGM: The company has scheduled its 41st Annual General Meeting for 19th September 2026. The record date for determining eligibility for the final dividend for FY26 has been fixed as 12th September 2026.
  • Segment-wise Performance:
    • Automation and Digitalisation: Segment revenue stood at Rs 728.39 lakh with an EBITDA of Rs 92.76 lakh.
    • Water: Segment revenue reached Rs 1,282.08 lakh with an EBITDA of Rs 291.45 lakh.
    • Industrial Engineering & Systems: Segment revenue was reported at Rs 2,888.36 lakh with an EBITDA of Rs 237.72 lakh.
  • Auditor Re-appointment: The Board approved the re-appointment of M/s. Chandabhoy & Jassoobhoy, Chartered Accountants, as Statutory Auditors for a second term of five consecutive years starting from the conclusion of the 41st AGM until the 46th AGM.
  • Leadership Updates: The Board recommended the re-appointment of Mr. Anand Shah as a Director, who is liable to retire by rotation. Mr. Shah has over 25 years of experience in Instrumentation and Control Engineering.
  • Consolidated Entities: The consolidated results include subsidiaries such as Axis New Energy Private Limited, Axis Analytics Private Limited, Axiot Informatics Private Limited, Brix Engineering GMBH (Germany), Brix Engineering Limited (UK), Axis Solutions FZE (Dubai), Brix Engineering PTE (Singapore), and AxisSol Arabia Company (Saudi Arabia).

Result PDF

Q1FY27 Quarterly Result Announced for Concord Biotech Ltd.

Biotechnology company Concord Biotech announced Q1FY27 results

Consolidated Financial Highlights:

  • Total revenue from operations for Q1FY27 stood at Rs 25,748.90 lakh, marking a YoY growth of 26.23% from Rs 20,398.76 lakh in Q1FY26, and a QoQ decline of 21.03% from Rs 32,607.96 lakh in Q4FY26.
  • Total income for Q1FY27 reached Rs 27,031.49 lakh, reflecting a 24.19% YoY increase compared to Rs 21,766.52 lakh and a 20.83% QoQ decrease from Rs 34,142.90 lakh.
  • The consolidated net profit for Q1FY27 was reported at Rs 5,769.69 lakh, representing a YoY growth of 30.96% from Rs 4,405.78 lakh in Q1FY26, and a decrease of 34.78% QoQ from Rs 8,846.69 lakh in Q4FY26.
  • Profit before tax for Q1FY27 stood at Rs 7,834.31 lakh, indicating a YoY increase of 33.39% from Rs 5,873.18 lakh in Q1FY26, while declining by 31.32% QoQ from Rs 11,407.54 lakh in Q4FY26.
  • Other income for the quarter reached Rs 1,282.59 lakh in Q1FY27, as against Rs 1,367.76 lakh in Q1FY26 and Rs 1,534.94 lakh in Q4FY26.
  • Total comprehensive income for Q1FY27 was Rs 7,475.83 lakh, compared to Rs 4,123.90 lakh in Q1FY26, marking a YoY growth of 81.28%.

Standalone Financial Highlights:

  • Revenue from operations for Q1FY27 was Rs 26,051.71 lakh, showing a YoY growth of 27.71% from Rs 20,398.76 lakh in Q1FY26, and a QoQ decrease of 20.06% from Rs 32,589.20 lakh in Q4FY26.
  • Total income for Q1FY27 stood at Rs 27,361.35 lakh, as against Rs 21,766.52 lakh in Q1FY26 (up 25.70% YoY) and Rs 34,143.37 lakh in Q4FY26 (down 19.86% QoQ).
  • Standalone net profit for Q1FY27 was reported at Rs 6,119.37 lakh, representing a significant YoY growth of 43.76% from Rs 4,256.55 lakh in Q1FY26, while falling 32.02% QoQ from Rs 9,002.21 lakh in Q4FY26.
  • Profit before tax for Q1FY27 reached Rs 8,220.96 lakh, compared to Rs 5,723.95 lakh in Q1FY26 and Rs 11,837.76 lakh in Q4FY26.
  • Total comprehensive income for the quarter was Rs 7,824.64 lakh in Q1FY27, up from Rs 3,974.67 lakh in Q1FY26.

Business Highlights:

  • Acquisition of Subsidiary: Celliimune Biotech Private Limited, which was incorporated on January 15, 2025, has been acquired by Concord Biotech Limited as on April 02, 2026. Consequently, Celliimune Biotech Private Limited has become a wholly owned subsidiary from April 02, 2026.
  • Consolidated Entities: The consolidated financial results include the results of the Parent Company (Concord Biotech Limited), its wholly owned subsidiaries (Concord Lifegen Limited and Celliimune Biotech Private Limited), its subsidiary (Stellon Biotech Inc.), and its joint venture (Concord Biotech Japan K.K.).
  • Regulatory Update: The company noted the notification of four Labour Codes by the Government of India in November 2025, which consolidate 29 existing labour laws. The Group had recognized an incremental liability of Rs 327.54 lakh towards employee benefit obligations in FY26 following an assessment based on the revised definition of wages under the New Labour Codes.

Result PDF

Q1FY27 Quarterly Result Announced for Gretex Corporate Services Ltd.

Financial Services company Gretex Corporate Services announced Q1FY27 results

Consolidated Financial Highlights:

  • Total revenue from operations for Q1FY27 was reported at Rs 3,752.09 lakh, reflecting a growth of 7.76% compared to Rs 3,481.74 lakh in Q4FY26 and a significant increase of 70.67% from Rs 2,198.42 lakh in Q1FY26.
  • Total income for Q1FY27 stood at Rs 3,806.59 lakh, an increase of 11.14% against Rs 3,425.12 lakh in Q4FY26 and up 67.92% from Rs 2,266.89 lakh in Q1FY26.
  • Net profit for the period for Q1FY27 reached Rs 1,279.96 lakh, representing a QoQ growth of 78.01% from Rs 719.05 lakh and a substantial YoY increase of 1,240.27% from Rs 95.50 lakh in Q1FY26.
  • Profit before tax for Q1FY27 was reported at Rs 1,719.46 lakh, reflecting a growth of 123.19% from Rs 770.39 lakh in Q4FY26 and an increase of 1,045.31% from Rs 150.13 lakh in Q1FY26.
  • Other income for Q1FY27 was Rs 54.50 lakh, compared to a loss of Rs 56.62 lakh in Q4FY26 and an income of Rs 68.47 lakh in Q1FY26.
  • Basic and Diluted earnings per share (EPS) for Q1FY27 stood at Rs 3.97, as against Rs 0.66 in Q4FY26 and Rs 0.42 in Q1FY26.
  • Total comprehensive income for the period was Rs 444.28 lakh in Q1FY27, compared to Rs 379.29 lakh in Q1FY26.

Standalone Financial Highlights:

  • Total revenue from operations for Q1FY27 was Rs 481.38 lakh, representing a decline of 20.24% from Rs 603.50 lakh in Q4FY26 and a marginal decrease of 2.73% from Rs 494.85 lakh in Q1FY26.
  • Total income for Q1FY27 stood at Rs 505.33 lakh, as against Rs 609.46 lakh in Q4FY26 and Rs 498.02 lakh in Q1FY26.
  • Net profit for the period for Q1FY27 was reported at Rs 210.14 lakh, a marginal QoQ decline of 1.83% from Rs 214.06 lakh and a YoY growth of 440.90% from Rs 38.85 lakh in Q1FY26.
  • Profit before tax for Q1FY27 was Rs 292.23 lakh, showing a growth of 250.82% over Rs 83.30 lakh in Q1FY26.
  • Other income for Q1FY27 was Rs 23.95 lakh, compared to Rs 5.96 lakh in Q4FY26 and Rs 3.17 lakh in Q1FY26.
  • Total comprehensive income for the period reached Rs 54.69 lakh in Q1FY27, as against Rs 117.21 lakh in Q1FY26.

Business Highlights:

  • Subsidiary Performance: Gretex Share Broking Limited (Subsidiary) reported total revenue of Rs 3,752.09 lakh and a total net profit after tax of Rs 1,279.96 lakh for the quarter ended Q1FY27.
  • Associate Performance: The Group's share of net profit after tax in its associate, Gretex Industries Limited, was Rs 137.24 lakh for the quarter ended Q1FY27.
  • Joint Venture Performance: The Group's share of net profit after tax in its joint venture, BahuTex Ventures LLP, was Rs 5.47 lakh for the quarter ended Q1FY27.
  • Group Structure: The consolidated results include the financial results of Gretex Share Broking Limited (Subsidiary), Gretex Industries Limited (Associate), and BahuTex Ventures LLP (Joint Venture).

Result PDF

Q1FY27 Quarterly Result Announced for Jindal Worldwide Ltd.

Textiles company Jindal Worldwide announced Q1FY27 results

Consolidated Financial Highlights:

  • Total Revenue: Consolidated Total Revenue reached Rs 57,295.75 lakh in Q1FY27, showing a YoY growth of 5.60% from Rs 54,259.75 lakh in Q1FY26. QoQ revenue saw a decline of 10.61% from Rs 64,095.35 lakh in Q4FY26.
  • Revenue from Operations: Consolidated revenue from operations was Rs 55,471.65 lakh in Q1FY27 vs Rs 53,989.74 lakh in Q1FY26, an increase of 2.74% YoY.
  • Profit Before Tax (PBT): Consolidated PBT stood at Rs 3,971.90 lakh in Q1FY27, a significant increase of 74.54% YoY from Rs 2,275.64 lakh in Q1FY26 and a 23.65% increase QoQ from Rs 3,212.20 lakh in Q4FY26.
  • Net Profit: Net Profit attributable to the group was Rs 3,240.54 lakh in Q1FY27, surging by 85.82% YoY from Rs 1,743.87 lakh in Q1FY26 and up 24.01% QoQ from Rs 2,613.18 lakh in Q4FY26.
  • Earnings Per Share (EPS): Basic and Diluted EPS improved to Rs 0.32 in Q1FY27 compared to Rs 0.17 in Q1FY26 and Rs 0.26 in Q4FY26.

Standalone Financial Highlights:

  • Total Revenue: The company recorded a Total Revenue of Rs 56,944.10 lakh in Q1FY27, representing a YoY increase of 18.68% from Rs 47,981.70 lakh in Q1FY26. On a QoQ basis, revenue decreased by 13.17% from Rs 65,578.80 lakh in Q4FY26.
  • Revenue from Operations: Revenue from operations stood at Rs 56,872.41 lakh in Q1FY27 compared to Rs 47,834.43 lakh in Q1FY26, a growth of 18.89%.
  • Profit Before Tax (PBT): PBT for Q1FY27 was Rs 2,003.77 lakh, up 8.89% YoY from Rs 1,840.07 lakh in Q1FY26, but down 33.55% QoQ from Rs 3,015.41 lakh in Q4FY26.
  • Net Profit: The company reported a Net Profit of Rs 1,479.06 lakh in Q1FY27, marking a YoY growth of 6.24% over Rs 1,392.13 lakh in Q1FY26 and a QoQ decline of 38.98% from Rs 2,423.75 lakh in Q4FY26.
  • Earnings Per Share (EPS): Basic and Diluted EPS stood at Rs 0.15 for Q1FY27 compared to Rs 0.14 in Q1FY26 and Rs 0.24 in Q4FY26.

Business Highlights:

  • Segment-wise Performance (Consolidated):
    • Textiles: This segment remains the primary revenue driver, contributing Rs 55,469.73 lakh in Q1FY27 (99.99% of total operation revenue) compared to Rs 53,989.74 lakh in Q1FY26. The segment profit before interest and tax stood at Rs 3,205.24 lakh.
    • Electric Vehicles: The segment recorded a nominal revenue of Rs 1.92 lakh in Q1FY27, down from Rs 768.40 lakh in Q4FY26. However, the segment reported a profit of Rs 1,567.75 lakh, largely influenced by the gain on disposal of interest in a subsidiary.
  • Operational Notes:
    • On 30th June 2026, the Group disposed of a 45% equity interest in its step-down subsidiary, EV Volt Pvt. Ltd. (formerly JM Volt Pvt. Ltd.), resulting in a loss of control. The resulting gain on disposal has been recognized under "Other Income" in the Statement of Profit and Loss.
    • On 31st March 2026, the Group had previously disposed of a 15% equity interest in EV Volt Pvt Ltd while retaining control, which was accounted for as an equity transaction.
    • The company noted that as of 20th May 2025, it sold its stake in June Industries Ltd (formerly Kashyap Tele-Medicine Limited), which subsequently ceased to be an associate.

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app